Hematology-Oncology Fellowship Training Program
Pasquale W. Benedetto, M.D.
Dalia Paz, coordinator, at 305-243-1032
JACKSON MEMORIAL HOSPITAL HEMATOLOGY-ONCOLOGY FELLOWSHIP TRAINING PROGRAM sponsored by Jackson Memorial Hospital is staffed and overseen by the Division of Hematology/Oncology in the Department of Internal Medicine at the Sylvester Comprehensive Cancer Center at the University of Miami’s Miller School of Medicine. It is an integral part of the ACGME-accredited educational program in Internal Medicine whose mission is to advance subspecialty education and patient care.
The Hematology/Oncology Fellowship Training Program offers a well-integrated fellowship training program which leads to eligibility for the Hematology and/or Oncology Board Examination after a three year training program. The fellowship program is accredited by ACGME. The combined program for Hematology and Oncology Board Certification includes the mandatory 18 months of clinical rotations over a 36 month fellowship. The remainder of time is distributed among research time (basic or clinical/translational research), elective rotations and vacation.
The Hematology/Oncology fellowship program offers a broad exposure to hematological and oncologic diseases in the in-patient and outpatient settings at four allied hospitals: University of Miami Hospital, Sylvester Comprehensive Cancer Center, Jackson Memorial Medical Center, and Miami Veterans Affairs Medical Center.
Applications are accepted through the Electronic Residency Application Service (ERAS) http://www.aamc.org/audienceeras.htm
The Jackson Memorial Hospital Hematology/Oncology Fellowship Training Program selects fellows through the National Residency Matching Program (NRMP). All fellowship applicants should have completed an ACGME-accredited internal medicine program. All applicants must submit their applications via ERAS. U.S. citizens, permanent residents, or physicians under H-1B or J-1 (exchange visitor program) can apply to our fellowship program.
The goal of the Hematology/Oncology Fellowship Training Program is to provide advanced education to allow the fellow to acquire competency in the subspecialties of Hematology and Medical Oncology with sufficient expertise to act as an independent consultant and to develop the ability to conduct clinical or basic scientific research.
Developing the skills, knowledge, and attitudes leading to proficiency in all the domains of clinical competency requires the fellow to assume personal responsibility for the care of individual patients. For the fellow, the essential learning activity is interaction with patients under the guidance and supervision of faculty members who give value, context, and meaning to those interactions. As fellows gain experience and demonstrate growth in their ability to care for patients, they assume roles that permit them to exercise those skills with greater independence. This concept—graded and progressive responsibility—is one of the core tenets of American graduate medical education.
During the course of the three years of fellowship training, the fellow acquires increasing sophistication in the delivery of hematologic/oncologic care as well as being exposed to basic science and clinical research. In the clinical care part of the fellowship the level of responsibility shifts increasingly from the attending to the fellow. During the first year the fellow has designated rotations encompassing 10-11 months of the year. Overall these rotations expose the incoming fellow to all of the components of the disciplines of hematology and oncology including care of hospitalized patients and outpatients. The fellow is exposed to hematologic malignancies including lymphoma, leukemia, myeloma, benign disorders such as TTP, sickle cell disease, coagulation disorders, bone marrow transplant, and solid tumor malignancies. Initially the fellow will take considerable direction from the attending on the inpatient units, the inpatient consultation service and the outpatient clinics but as time passes and experience increases the fellow will assume more responsibility for the development and execution of the plan of care. During the second year, 6-7 months are designated clinical rotations. Clinical electives are available in the following areas: Pediatric Hematology/Oncology, Blood Banking, Pheresis and Marrow Processing Laboratory, Coagulation Laboratory, Surgical Pathology, Hematopathology, Radiation Oncology, Gynecologic Oncology, and Urologic Oncology. In addition the fellow may opt for mentored clinical rotations inside of specific Site Disease Groups or with selected individual attendings in a one-on-one educational situation usually in areas of specialty interest. The remainder of the year is designated “elective” and includes time for clinical or lab-based research. In the third year the fellow has 2 to 3 inpatient rotations and the rest of the time is elective.At this point in time the fellows have completed the major portion of inpatient experiences and should be familiar, comfortable and confidant with essentially all the common and many uncommon problems in hematology-oncology. Increasingly the fellows are capable of independent practice with attending oversight providing validation. These experiences further confirm the fellow’s capacity to function at the level of a certified practitioner. This increasing autonomy develops with exposure to the discipline and with input by the faculty. The progress leading to autonomy is documented by the faculty evaluations of the fellow and reviewed at the time of the semi-annual evaluations with the Program Director.
As part of the only Academic Medical Center in South Florida, the Sylvester Comprehensive Cancer Center is at the forefront of advanced new treatments and cutting edge technology. This allows our team of cancer experts to develop and pioneer highly innovative strategies to fight some of the most aggressive and deadly forms of cancer. There are more than 250 physicians and scientists dedicated to cancer care and research. Every day, our physicians and scientists within the cancer center’s 15 site disease groups and 7 multidisciplinary research programs, are discovering exciting new breakthroughs that are quickly transforming the way cancer patients are diagnosed and treated. Translating research breakthroughs into more effective treatments remains one of Sylvester’s highest priorities. Sylvester conducts more clinical research than any other institution in South Florida and has a wide range of trials, with 168 currently underway.
Scientists at Sylvester are grouped into seven multidisciplinary research programs
Biobehavioral Oncology Program
Molecular Oncology and Experimental Therapeutics Program
Tumor Immunobiology Program
Viral Oncology Program
Breast Cancer Program
Cancer Epidemiology & Prevention Program
Genitourinary Malignancies Program
The fellows are expected to develop research projects during their training . Projects are tailored to each fellow’s interests and can include anything from basic science research to design of a clinical trial or clinical outcomes research. During the first year the fellow will identify a mentor and with their guidance devise an appropriate research project that can be completed by the end of their fellowship. The fellow will meet on a regular basis with mentor and the fellowship director to determine progress on their project. Fellows are expected to present and/or publish the results of their work in a peer reviewed journal. Research electives may also be developed in conjunction with clinical or laboratory faculty research mentors.
Read about the latest UHealth news here
For a full list of our Hematology-Oncology Physicians, click here